End Fund Inc

Programs: The end fund focuses on delivering neglected tropical disease (ntd) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with governmnet, ngo, pharmaceutical, and academic partners. We aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending ntds. Neglected tropical diseases (ntds) are a group of parasitic and bacterial infectious diseases that affect more than 1. 5 billion of the worlds poorest people, including 836 million children. Over 40% of the global ntd burden is concentrated in sub-saharan africa, where the end fund focuses the majority of its work. Ntds rank among the four most devastating groups of communicable diseases. They cause severe pain, long-term disability, blindness and lead to death for more than 170,000 people per year. Amongst children, infection leads to malnutrition, cognitive impairment, stunted growth, and the inability to attend school. Social isolation and physical ailments can make working difficult for people with ntds. Many people are unable to provide for themselves or their families and are left in a cycle of poverty. Studies show that ntd treatment is the single most cost-effective means of improving childrens attendance and increasing capacity to learn and concentrate in school. Just 50 cents funds delivery of a rapid-impact package of medication to treat an individual for a year for the five most common ntds, making it a best buy in public health. As a fund, our unique model enables us to act quickly and effectively, with a proven ability to leverage the efficiencies of the private sector and foster strong partnerships. We are able to mobilize resources from a diverse range of investors and direct them to partners who can deliver them where they will have the most impact. Our strategy consists of growing and engaging a community of activist philanthropists dedictated to ending ntds; raising and allocating capital effectively to end ntds; serving as a platform for donor coordination, collaboration, and leverage; engaging as a technical, strategic, and advocacy partner with governments, local and international non-governmental organizations, academic institutions, pharmaceutical companies, multi-laterals, funders, and private sector business leaders; actively managing a portfolio of high-impact, strategic investments to scale treatment and reach disease elimination goals; fostering innovation and fast-tracking the development of new ntd tools and technology; leading targeted outreach, advocacy, and awareness efforts to share the investment opportunity and large-scale social impact of ending ntds with key public and private sector leaders and decision-makers; monitoring and evaluating the impact of our portfolio of investments and contributing learnings and best practices to the broader ntd and global health communities; and, taking a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending ntds. In close partnership with stakeholders across the global ntd community the end fund: identifies gaps and opportunities- understands investment needs and gaps, landscapes investable opportunities, and increases coordination among stakeholders; builds coalitions- mobilizes and activates collaboration among country-level stakeholders, including ministries of health, ngos, donors, etc. ; designs programs- works with implementing partner ngos to expand data collection, mapping, and sector knowledge in order to identify compelling program opportunities; strengthens capacity- aims to grow and strengthen the pool of partner organizations to assist local governments in the implementation of quality ntd programs; manages grants and provides technical support- conducts country program visits and provides partner support, technical assistance, and capacity building as needed; and conducts monitoring, evaluation, and program communications- designs and executes monitoring, evaluation, and information sharing activities to inform program design, organizational decision making, and donor updates.